← Open Payments lookup

DAN JACOBS: Open Payments

NPI 1831213263 · FORT WASHINGTON, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,911 in 175 payments from 13 companies in 2025. Trend: 2023 $1,469 · 2024 $1,710 · 2025 $1,911

Food & beverage: $1,911
CompanyPaymentsAmount
ABBVIE INC.54$331
Otsuka America Pharmaceutical, Inc.25$307
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)35$261
Neurocrine BioSciences, Inc.17$239
Vanda Pharmaceuticals Inc.13$236
Takeda Pharmaceuticals U.S.A., Inc.11$149
Alkermes, Inc.6$127
Lundbeck LLC6$94
E.R. Squibb & Sons, L.L.C.2$47
Axsome Therapeutics, Inc.2$42

Products named: REXULTI, VRAYLAR, CAPLYTA, INGREZZA, FANAPT, TRINTELLIX, ARISTADA, COBENFY.

Industry payments across PA — which companies pay providers there.